ZBiotics, Maker of World’s First Genetically Engineered Probiotics, Raises $12M Series A
Summary
The company will use the funds to meet growing consumer demand, spearhead retail expansion, and drive continued research and development in a new sector, including bringing new genetically engineered probiotic products to market that address the unique and newly arising biological challenges of modern living. Genetic engineering allows us to make totally new products that address real-world consumer needs, and were witnessing a growing interest in our technology and brand," stated Zack Abbott, Ph.D., co-founder and CEO of ZBiotics. Fundamentally driven by the mission of making people healthier through modern biotechnology, ZBiotics has created a company that provides consumers with sustainable, effective solutions that cannot and do not exist without genetic engineering. Off of the breakout success of their first product, ZBiotics has more than doubled sales every year, selling over 5 million units cumulatively and reaching company-wide profitability in 2023, said Adam Ramada, co-managing partner of Spring Tide Capital. The funds will also be used to launch the ZBiotics brand into physical retail spaces, aligning with the long-term vision of the company to make proudly GMO products more accessible to the consumers who benefit from their solutions.